Effectiveness of Pars Plana Vitrectomy in Treating Symptomatic Vitreous Floaters Linked to Fuchs Heterochromic Iridocyclitis
By
Mehmet Sahin Sevim
Semra Sevim
March 7, 2026
Clinical Scorecard: Effectiveness of Pars Plana Vitrectomy in Treating Symptomatic Vitreous Floaters Linked to Fuchs Heterochromic Iridocyclitis
At a Glance
Category Detail
Condition Fuchs heterochromic uveitis (FHU) Key Mechanisms Chronic low-grade anterior chamber inflammation leading to vitreous opacities and visual impairment. Target Population Young adult Caucasian individuals with FHU experiencing symptomatic vitreous floaters. Care Setting Ophthalmology clinic, specifically a uveitis unit.
Key Highlights
Pars plana vitrectomy (PPV) evaluated for symptomatic vitreous floaters in FHU patients. Study included 17 eyes of 17 patients who had prior uncomplicated cataract surgery. Postoperative evaluations included best-corrected visual acuity (BCVA) and optical coherence tomography (OCT). Significant visual impairment due to inflammatory vitreous opacities was noted. Surgical outcomes assessed at 1 and 3 months postoperatively. Guideline-Based Recommendations
Diagnosis
Confirm diagnosis of Fuchs heterochromic uveitis through clinical evaluation. Management
Consider pars plana vitrectomy for patients with visually significant vitreous opacities. Monitoring & Follow-up
Regular follow-up for BCVA, intraocular pressure, and OCT assessments postoperatively. Risks
Potential for iatrogenic retinal breaks during surgery; monitor for retinal tears postoperatively. Patient & Prescribing Data
Patients with Fuchs heterochromic uveitis and symptomatic vitreous floaters.
Topical prednisolone acetate and moxifloxacin prescribed postoperatively.
Clinical Best Practices
Perform thorough preoperative evaluation including BCVA and intraocular pressure measurement. Utilize standard three-port pars plana vitrectomy technique. Conduct meticulous peripheral retinal examination post-surgery. References
